Documented cause
Clover Health launched in 2014 as a technology-forward Medicare Advantage plan — health insurance for seniors funded by the federal government. Its pitch was that a proprietary software platform, the Clover Assistant, would show physicians data-driven recommendations during patient visits, improving care outcomes and reducing costs. Vivek Garipalli and Andrew Toy founded the company and raised over $1.3 billion before pursuing a SPAC merger.
In October 2020, Clover announced it would merge with Social Capital Hedosophia VI, a SPAC run by venture capitalist Chamath Palihapitiya, at a $3.7 billion valuation. The SPAC closed in January 2021. Clover debuted as a public company to significant fanfare, with Palihapitiya promoting the company aggressively on social media.
In February 2021 — just weeks after the SPAC closed — Hindenburg Research published a short-seller report alleging that Clover's SPAC filing had failed to disclose that the Department of Justice was investigating the company for potential violations related to kickbacks, marketing payments to agents, and other practices. The report also alleged that the Clover Assistant's AI capabilities were significantly exaggerated and that much of the data work was done manually by offshore contractors. Clover's stock, which had traded above $15, fell more than 30% the day the report published. The company confirmed the DoJ investigation was real. Subsequent years brought continued underwriting losses, geographic expansion challenges, and a stock that fell to under $0.50. By 2023, Clover had exited several markets and was restructuring. The DoJ investigation resolved without criminal charges, but the disclosure failure destroyed the company's credibility.